marketcaparena
Search

    LIVN

    LivaNova PLC

    Company overview

    Market capitalization
    $4.25B
    Employees
    3,300
    Latest publication
    2026-09-29
    About LivaNova PLC

    LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of LivaNova's aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, other healthcare professionals, hospitals, and other medical institutions and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue390,587,000USD362,258,000USD360,855,000USD357,800,000USD352,524,000USD316,855,000USD321,830,000USD318,120,000USD
    Cost Of Revenue116,917,000USD117,409,000USD121,080,000USD112,900,000USD113,536,000USD96,080,000USD102,476,000USD92,856,000USD
    Gross Profit273,670,000USD244,849,000USD239,775,000USD244,900,000USD238,988,000USD220,775,000USD219,354,000USD225,264,000USD
    Research Development53,662,000USD49,095,000USD52,079,000USD48,600,000USD47,185,000USD37,879,000USD43,308,000USD48,805,000USD
    Selling General Administrative158,128,000USD143,568,000USD143,365,000USD138,522,000USD137,780,000USD133,667,000USD135,623,000USD131,661,000USD
    Total Operating Expenses224,186,000USD192,663,000USD197,158,000USD190,900,000USD184,805,000USD172,158,000USD182,333,000USD189,646,000USD
    Operating Income49,484,000USD52,186,000USD42,617,000USD54,000,000USD54,183,000USD48,617,000USD37,021,000USD35,618,000USD
    Total Other Income Expense Net-31,005,000USD-25,552,000USD-14,963,000USD-20,100,000USD-20,871,000USD-364,283,000USD19,459,000USD8,860,000USD
    Interest Expense7,176,000USD8,291,000USD19,786,000USD10,863,000USD12,280,000USD15,286,000USD15,767,000USD15,878,000USD
    Income Before Tax18,479,000USD26,634,000USD27,654,000USD33,900,000USD33,312,000USD-315,666,000USD56,480,000USD44,478,000USD
    Income Tax Expense-90,204,000USD4,340,000USD-3,207,000USD7,114,000USD6,151,000USD11,656,000USD589,000USD11,525,000USD
    Equity Method Income Loss-114,000USD———————
    Net Income108,569,000USD22,300,000USD30,878,000USD26,800,000USD27,161,000USD-327,322,000USD55,891,000USD32,953,000USD
    Interest Income—3,552,000USD4,457,000USD3,899,000USD4,183,000USD6,443,000USD8,578,000USD7,139,000USD
    Net Interest Income—-4,739,000USD-6,400,000USD-6,964,000USD-8,097,000USD-8,843,000USD-7,189,000USD-8,739,000USD
    Tax Provision—4,340,000USD-3,282,000USD7,114,000USD6,151,000USD11,656,000USD589,000USD11,525,000USD
    Net Income From Continuing Ops—22,294,000USD30,906,000USD26,784,000USD27,161,000USD-327,322,000USD55,891,000USD32,953,000USD
    Ebit—34,925,000USD47,440,000USD44,763,000USD45,600,000USD-300,360,000USD72,247,000USD60,319,000USD
    Ebitda—50,520,000USD47,478,000USD57,014,000USD60,640,000USD-285,689,000USD84,830,000USD73,447,000USD
    Depreciation And Amortization—15,595,000USD38,000USD12,251,000USD15,040,000USD14,671,000USD12,583,000USD13,128,000USD
    Reconciled Depreciation—15,595,000USD14,706,000USD15,215,000USD15,040,000USD14,671,000USD12,583,000USD13,128,000USD
    Unclassified Operating Expenses———3,778,000USD——3,402,000USD9,180,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20212021-12-31 · USDFY 20182018-12-31 · USDFY 20132013-12-31 · USDFY 20032003-12-31 · USDFY 20022002-12-31 · USDFY 20002000-12-31 · USD
    Total Revenue1,388,100,000USD1,253,437,000USD1,035,365,000USD1,107,000,000USD282,014,160USD110,721,499USD104,466,998USD43,419,000USD
    Cost Of Revenue448,200,000USD382,564,000USD329,371,000USD372,500,000USD27,354,891USD16,295,562USD16,066,229USD9,385,000USD
    Gross Profit939,900,000USD870,873,000USD705,994,000USD734,500,000USD254,659,269USD94,425,937USD88,400,769USD34,034,000USD
    Research Development185,800,000USD182,514,000USD183,414,000USD146,000,000USD46,562,775USD17,133,709USD17,874,909USD17,201,000USD
    Selling General Administrative548,813,000USD526,265,000USD471,900,000USD462,413,000USD167,205,000USD87,730,000USD83,717,000USD50,772,000USD
    Total Operating Expenses740,500,000USD741,822,000USD706,778,000USD648,200,000USD167,204,672USD87,730,858USD83,717,147USD—
    Operating Income199,400,000USD129,051,000USD-784,000USD-248,100,000USD80,011,750USD6,695,079USD4,683,622USD—
    Interest Income18,982,000USD30,075,000USD435,000USD847,000USD————
    Interest Expense49,286,000USD63,070,000USD50,151,000USD9,825,000USD20,048USD565,702USD565,702USD0USD
    Net Interest Income-30,304,000USD-32,995,000USD-49,700,000USD-8,978,000USD————
    Income Before Tax-220,800,000USD88,310,000USD-124,620,000USD-247,400,000USD79,878,696USD6,990,298USD5,314,494USD—
    Income Tax Expense21,600,000USD25,058,000USD11,198,000USD-69,629,000USD24,988,439USD26,113USD230,789USD—
    Tax Provision21,639,000USD25,058,000USD11,200,000USD-69,629,000USD————
    Net Income-242,500,000USD63,234,000USD-135,818,000USD-189,400,000USD54,890,257USD6,759,509USD5,184,931USD—
    Net Income From Continuing Ops-242,471,000USD63,234,000USD-135,800,000USD-178,462,000USD54,890,000USD———
    Ebit-171,500,000USD151,380,000USD-74,321,000USD-237,688,000USD87,341,591USD-19,782,328USD6,492,570USD—
    Ebitda-129,500,000USD202,524,000USD-6,333,000USD-167,748,000USD92,944,084USD-14,864,277USD11,613,131USD—
    Depreciation And Amortization42,000,000USD51,144,000USD67,988,000USD69,940,000USD5,602,493USD4,918,051USD5,120,561USD—
    Reconciled Depreciation59,632,000USD51,144,000USD67,900,000USD69,940,000USD————
    Total Other Income Expense Net-420,200,000USD-40,741,000USD-123,836,000USD625,000USD642,000USD712,954USD-1,846,352USD—
    Unclassified Operating Expenses—33,043,000USD51,464,000USD39,787,000USD-46,563,103USD-17,132,851USD-17,874,762USD—
    Non Operating Income Net Other——-59,951,000USD11,687,000USD————
    Net Income Applicable To Common Shares——-135,800,000USD-189,399,000USD54,890,000USD6,760,000USD5,185,000USD—
    Discontinued Operations———-10,937,000USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets2,640,861,000USD2,516,400,000USD2,606,100,000USD2,557,583,000USD2,506,702,000USD2,558,746,000USD2,506,389,000USD2,521,958,000USD
    Cash And Equivalents516,619,000USD———————
    Long Term Investments15,270,000USD18,492,000USD20,291,000USD15,049,000USD16,163,000USD22,721,000USD25,084,000USD18,097,000USD
    Total Current Assets1,025,045,000USD1,014,200,000USD1,101,600,000USD1,097,149,000USD1,066,142,000USD1,171,151,000USD1,127,186,000USD1,093,113,000USD
    Other Current Assets61,641,000USD79,700,000USD85,300,000USD44,422,000USD54,174,000USD47,277,000USD327,060,000USD387,321,000USD
    Other Non Current Assets18,310,000USD———————
    Total Liabilities1,315,539,000USD———————
    Total Current Liabilities707,004,000USD762,500,000USD808,100,000USD827,588,000USD827,100,000USD741,573,000USD392,125,000USD324,402,000USD
    Other Current Liabilities103,831,000USD———————
    Other Non Current Liabilities50,652,000USD———————
    Total Stockholder Equity1,325,322,000USD1,211,300,000USD1,200,000,000USD1,157,230,000USD1,122,839,000USD1,034,298,000USD1,320,258,000USD1,310,044,000USD
    Total Equity Including Noncontrolling Interest1,325,322,000USD———————
    Long Term Debt289,908,000USD285,160,000USD345,185,000USD349,031,000USD348,489,000USD549,223,000USD549,624,000USD604,287,000USD
    Net Receivables231,303,000USD229,300,000USD216,000,000USD239,110,000USD252,980,000USD231,420,000USD223,702,000USD197,162,000USD
    Inventory172,612,000USD165,500,000USD164,700,000USD167,538,000USD165,350,000USD154,017,000USD147,566,000USD162,264,000USD
    Property Plant Equipment Net330,047,000USD310,000,000USD298,100,000USD269,707,000USD246,095,000USD225,841,000USD217,097,000USD220,916,000USD
    Goodwill779,144,000USD———————
    Intangible Assets217,003,000USD224,600,000USD230,000,000USD234,530,000USD239,143,000USD236,594,000USD237,294,000USD248,545,000USD
    Accounts Payable103,392,000USD99,100,000USD97,200,000USD88,156,000USD86,934,000USD87,640,000USD69,726,000USD77,893,000USD
    Short Term Debt3,583,000USD2,600,000USD31,500,000USD94,441,000USD91,513,000USD88,301,000USD87,044,000USD31,428,000USD
    Common Stock84,599,000USD83,398,000USD—84,520,000USD84,521,000USD84,446,000USD83,156,000USD83,112,000USD
    Retained Earnings-1,014,858,000USD-1,123,427,000USD-1,145,721,000USD-1,176,627,000USD-1,203,411,000USD-1,230,572,000USD-903,250,000USD-959,141,000USD
    Accumulated Other Comprehensive Income-14,386,000USD-3,401,000USD—5,508,000USD8,113,000USD-42,728,000USD-80,170,000USD-26,703,000USD
    Total Liab—1,305,000,000USD1,406,100,000USD1,400,353,000USD1,383,863,000USD1,524,448,000USD1,186,131,000USD1,211,914,000USD
    Other Current Liab—619,100,000USD646,300,000USD633,907,000USD602,982,000USD514,634,000USD192,051,000USD178,295,000USD
    Capital Stock—84,564,000USD84,564,000USD84,520,000USD84,521,000USD84,446,000USD83,156,000USD83,112,000USD
    Good Will—785,600,000USD792,800,000USD791,034,000USD793,365,000USD761,911,000USD750,006,000USD781,553,000USD
    Cash—539,700,000USD635,600,000USD646,079,000USD593,638,000USD738,437,000USD428,858,000USD346,366,000USD
    Cash And Short Term Investments—539,700,000USD635,600,000USD646,079,000USD593,638,000USD738,437,000USD428,858,000USD346,366,000USD
    Net Debt—-205,200,000USD-162,300,000USD-159,532,000USD-110,859,000USD-60,586,000USD247,915,000USD333,427,000USD
    Short Long Term Debt—2,628,000USD31,472,000USD85,440,000USD82,133,000USD79,570,000USD78,004,000USD21,951,000USD
    Short Long Term Debt Total—334,500,000USD473,300,000USD486,547,000USD482,779,000USD677,851,000USD676,773,000USD679,793,000USD
    Property Plant Equipment Gross—310,015,000USD540,328,000USD269,707,000USD246,095,000USD225,841,000USD423,850,000USD220,916,000USD
    Common Stock Shares Outstanding—55,900,000shares54,500,000shares55,200,000shares54,708,000shares54,421,000shares54,700,000shares54,585,000shares
    Non Current Assets Total—1,502,200,000USD1,504,500,000USD1,460,434,000USD1,440,560,000USD1,387,595,000USD1,379,203,000USD1,428,845,000USD
    Non Current Liabilities Total—542,500,000USD597,999,999USD572,765,000USD556,763,000USD782,875,000USD794,006,000USD887,512,000USD
    Non Current Liabilities Other—97,520,000USD97,414,000USD92,505,000USD92,361,000USD132,434,000USD128,696,000USD128,280,000USD
    Non Currrent Assets Other—53,700,000USD52,300,000USD42,809,000USD35,984,000USD31,073,000USD37,867,000USD49,742,000USD
    Net Working Capital—251,759,000USD293,541,000USD269,561,000USD239,042,000USD429,578,000USD735,061,000USD768,711,000USD
    Unclassified Non Current Assets—109,808,000USD111,009,000USD107,305,000USD109,810,000USD109,455,000USD111,855,000USD109,992,000USD
    Unclassified Current Liabilities—39,072,000USD—-85,440,000USD-47,638,000USD-40,021,000USD-45,548,000USD4,556,000USD
    Unclassified Non Current Liabilities—159,820,000USD155,400,999USD131,229,000USD115,913,000USD101,218,000USD115,686,000USD154,945,000USD
    Unclassified Equity—2,170,166,000USD2,261,157,000USD2,159,309,000USD2,149,095,000USD2,138,706,000USD2,137,366,000USD2,129,664,000USD
    Current Deferred Revenue———11,084,000USD11,176,000USD11,449,000USD10,848,000USD10,279,000USD
    Other Assets——————-14,000USD—
    Short Term Investments——————42,000USD3,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets2,606,100,000USD2,506,389,000USD2,429,563,000USD2,294,773,000USD2,200,951,000USD2,399,961,000USD2,411,797,000USD2,549,700,000USD
    Intangible Assets230,000,000USD237,294,000USD261,178,000USD368,559,000USD399,682,000USD437,636,000USD607,546,000USD770,400,000USD
    Other Current Assets85,300,000USD327,060,000USD358,695,000USD327,767,000USD142,374,000USD154,771,000USD65,782,999USD29,600,000USD
    Total Liab1,406,100,000USD1,186,131,000USD1,151,935,000USD1,087,149,000USD906,306,000USD1,290,696,000USD1,028,079,999USD1,046,000,000USD
    Total Stockholder Equity1,200,000,000USD1,320,258,000USD1,277,628,000USD1,207,624,000USD1,294,645,000USD1,109,265,000USD1,383,717,000USD1,503,700,000USD
    Other Current Liab646,300,000USD192,051,000USD193,600,000USD163,544,000USD364,477,000USD187,373,000USD325,436,000USD-100,000USD
    Capital Stock84,564,000USD83,156,000USD82,533,000USD82,424,000USD82,295,000USD76,300,000USD76,257,000USD76,144,000USD
    Retained Earnings-1,145,721,000USD-903,250,000USD-966,484,000USD-984,030,000USD-897,784,000USD-761,966,000USD-406,755,000USD-251,579,000USD
    Good Will792,800,000USD750,006,000USD782,941,000USD768,787,000USD899,525,000USD922,318,000USD915,794,000USD956,800,000USD
    Cash635,600,000USD428,858,000USD266,504,000USD214,172,000USD207,992,000USD252,832,000USD61,137,000USD47,200,000USD
    Cash And Short Term Investments635,600,000USD428,858,000USD266,504,000USD214,172,000USD207,992,000USD252,832,000USD61,137,000USD47,200,000USD
    Total Current Assets1,101,600,000USD1,127,186,000USD988,158,000USD886,136,000USD679,181,000USD708,044,000USD549,443,000USD533,300,000USD
    Total Current Liabilities808,100,000USD392,125,000USD334,983,000USD297,398,000USD696,970,000USD309,052,000USD512,553,000USD496,700,000USD
    Net Debt-162,300,000USD247,915,000USD373,900,000USD366,256,000USD78,710,000USD456,306,000USD333,726,000USD121,100,000USD
    Short Term Debt31,500,000USD87,044,000USD26,473,000USD32,813,000USD240,934,000USD24,619,000USD88,506,000USD28,800,000USD
    Short Long Term Debt31,472,000USD78,004,000USD18,111,000USD23,434,000USD229,700,000USD13,300,000USD77,396,000USD28,794,000USD
    Short Long Term Debt Total473,300,000USD676,773,000USD640,404,000USD580,428,000USD286,702,000USD709,138,000USD394,863,000USD168,338,000USD
    Long Term Debt345,185,000USD549,624,000USD568,543,000USD518,067,000USD9,800,000USD642,298,000USD260,330,000USD139,538,000USD
    Long Term Investments20,291,000USD25,084,000USD22,843,000USD16,266,000USD16,600,000USD103,396,000USD27,256,000USD27,455,000USD
    Net Receivables216,000,000USD223,702,000USD215,072,000USD214,818,000USD222,975,000USD185,156,000USD258,369,000USD256,100,000USD
    Inventory164,700,000USD147,566,000USD147,887,000USD129,379,000USD105,840,000USD115,285,000USD164,154,000USD153,500,000USD
    Accounts Payable97,200,000USD69,726,000USD80,845,000USD74,310,000USD68,000,000USD73,668,000USD85,892,000USD76,700,000USD
    Property Plant Equipment Net298,100,000USD217,097,000USD205,026,000USD183,017,000USD190,666,000USD214,330,000USD235,726,000USD191,400,000USD
    Property Plant Equipment Gross540,328,000USD423,850,000USD401,062,000USD183,000,000USD190,700,000USD214,330,000USD235,726,000USD191,400,000USD
    Common Stock Shares Outstanding54,500,000shares54,574,000shares54,212,000shares53,500,000shares50,633,000shares48,592,000shares48,349,000shares48,497,000shares
    Non Current Assets Total1,504,500,000USD1,379,203,000USD1,441,405,000USD1,408,637,000USD1,521,770,000USD1,691,917,000USD1,862,354,000USD2,016,300,000USD
    Non Current Liabilities Total597,999,999USD794,006,000USD816,952,000USD789,751,000USD209,336,000USD981,643,999USD515,526,999USD549,300,000USD
    Non Current Liabilities Other97,414,000USD128,696,000USD128,631,000USD131,141,000USD136,900,000USD210,317,000USD129,776,000USD184,016,000USD
    Non Currrent Assets Other52,300,000USD37,867,000USD50,559,000USD70,624,000USD13,102,000USD11,247,000USD7,356,000USD4,800,000USD
    Net Working Capital293,541,000USD735,061,000USD653,175,000USD588,738,000USD-17,800,000USD410,382,000USD36,890,000USD36,551,000USD
    Unclassified Non Current Assets111,009,000USD-242,181,000USD118,858,000USD-70,624,000USD——68,676,000USD65,345,000USD
    Unclassified Non Current Liabilities155,400,999USD115,686,000USD119,778,000USD-101,593,000USD-101,064,000USD-300,826,001USD-83,688,001USD-251,793,000USD
    Unclassified Equity2,261,157,000USD2,137,366,000USD2,106,929,000USD2,074,925,000USD2,035,666,000USD1,691,856,001USD1,658,613,000USD1,628,929,000USD
    Common Stock—83,156,000USD82,533,000USD82,424,000USD82,295,000USD76,300,000USD76,257,000USD76,144,000USD
    Other Assets—354,036,000USD—72,008,000USD15,300,000USD200,000USD-100,000USD100,000USD
    Current Deferred Revenue—10,848,000USD10,725,000USD10,226,000USD8,419,000USD6,929,000USD6,728,000USD391,300,000USD
    Accumulated Other Comprehensive Income—-80,170,000USD-27,883,000USD-48,119,000USD-7,177,000USD27,808,999USD-19,392,000USD-24,476,000USD
    Unclassified Current Liabilities—-45,548,000USD5,229,000USD-6,929,000USD-214,560,000USD3,163,000USD-71,405,000USD-28,894,000USD
    Other Liab———242,136,000USD163,700,000USD299,000,000USD209,109,000USD409,350,000USD
    Short Term Investments———-34,000USD-2,000USD31,094,000USD—2,655,000USD
    Net Tangible Assets———70,278,000USD-4,600,000USD-241,125,000USD-139,623,000USD-223,516,000USD
    Treasury Stock————-650,000USD-1,034,000USD-1,263,000USD-1,462,000USD
    Deferred Long Term Liab—————130,855,000USD—68,189,000USD
    Unclassified Current Assets—————-31,094,000USD—44,245,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income22,294,000USD30,906,000USD26,784,000USD27,161,000USD-327,322,000USD55,891,000USD32,953,000USD16,333,000USD
    Depreciation15,595,000USD14,706,000USD15,215,000USD7,278,000USD14,671,000USD12,583,000USD13,128,000USD12,294,000USD
    Stock Based Compensation8,270,000USD9,388,000USD9,947,000USD9,174,000USD7,783,000USD6,949,000USD8,559,000USD8,199,000USD
    Other Non Cash Items27,525,000USD11,879,000USD23,496,000USD12,343,000USD-9,268,000USD-27,790,000USD-5,735,000USD13,555,000USD
    Change To Account Receivables-14,669,000USD-4,875,000USD7,842,000USD-9,776,000USD-3,896,000USD-6,365,000USD9,027,000USD6,407,000USD
    Change To Inventory-1,546,000USD2,809,000USD-2,062,000USD-3,544,000USD-2,494,000USD7,138,000USD-2,957,000USD-2,792,000USD
    Change In Working Capital-60,292,000USD19,129,000USD8,312,000USD6,445,000USD335,858,000USD33,372,000USD-1,448,000USD-7,781,000USD
    Total Cash From Operating Activities15,216,000USD82,400,000USD85,057,000USD62,920,000USD23,966,000USD78,707,000USD50,994,000USD43,356,000USD
    Capital Expenditures-14,290,000USD-32,200,000USD-22,880,000USD-15,147,000USD-10,790,000USD-10,406,000USD-18,147,000USD-12,156,000USD
    Free Cash Flow926,000USD50,200,000USD62,177,000USD47,773,000USD13,176,000USD68,301,000USD32,847,000USD31,200,000USD
    Total Cashflows From Investing Activities-14,580,000USD-30,259,000USD-23,057,000USD-8,968,000USD-10,628,000USD-10,708,000USD-18,520,000USD-12,569,000USD
    Net Borrowings-95,938,000USD-64,114,000USD-6,563,000USD-205,875,000USD-4,375,000USD-4,372,000USD-4,424,000USD—
    Total Cash From Financing Activities-94,245,000USD-62,884,000USD-9,373,000USD-208,982,000USD-4,421,000USD-3,444,000USD-3,282,000USD-11,870,000USD
    Change In Cash-95,846,000USD-10,527,000USD52,441,000USD-144,799,000USD14,881,000USD56,980,000USD33,455,000USD17,438,000USD
    Begin Period Cash Flow635,552,000USD646,079,000USD593,638,000USD738,437,000USD723,556,000USD666,576,000USD633,121,000USD615,683,000USD
    End Period Cash Flow539,706,000USD635,600,000USD646,079,000USD593,638,000USD738,437,000USD723,556,000USD666,576,000USD633,121,000USD
    Other Cashflows From Investing Activities-290,000USD1,941,000USD-177,000USD-343,000USD162,000USD-6,000USD99,000USD-39,000USD
    Other Cashflows From Financing Activities1,693,000USD2,033,000USD-3,099,000USD774,000USD-46,000USD1,296,000USD1,088,000USD314,000USD
    Unclassified Operating Cash Flow1,824,000USD-3,608,000USD1,303,000USD—2,244,000USD-2,298,000USD3,537,000USD—
    Investments—-5,665,000USD-23,057,000USD-8,968,000USD-10,628,000USD-10,708,000USD-18,520,000USD-12,569,000USD
    Sale Purchase Of Stock—-805,000USD256,000USD-3,881,000USD—-368,000USD54,000USD-7,809,000USD
    Unclassified Investing Cash Flow—5,665,000USD23,057,000USD15,490,000USD10,628,000USD10,412,000USD18,048,000USD12,195,000USD
    Unclassified Financing Cash Flow———————-4,375,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-242,500,000USD63,234,000USD17,546,000USD-86,200,000USD-135,818,000USD-345,000,000USD-157,639,000USD-189,400,000USD
    Depreciation42,000,000USD51,144,000USD60,856,000USD57,800,000USD67,988,000USD81,300,000USD82,989,000USD69,900,000USD
    Stock Based Compensation36,300,000USD33,933,000USD36,352,000USD44,809,000USD40,564,000USD35,089,000USD32,553,000USD26,900,000USD
    Other Non Cash Items48,030,000USD26,626,000USD109,208,000USD83,800,000USD97,736,000USD222,900,000USD39,794,000USD303,400,000USD
    Change To Account Receivables-10,700,000USD11,100,000USD-28,864,000USD-4,800,000USD-15,745,000USD58,800,000USD-5,321,000USD21,200,000USD
    Change To Inventory-5,300,000USD-6,800,000USD-28,478,000USD-25,700,000USD4,484,000USD1,400,000USD-7,924,000USD-10,600,000USD
    Change In Working Capital369,970,000USD1,306,000USD-34,620,000USD-31,700,000USD29,222,000USD-111,000,000USD-62,341,000USD4,800,000USD
    Total Cash From Operating Activities254,300,000USD183,038,000USD74,914,000USD69,900,000USD102,544,000USD-79,400,000USD-91,142,000USD120,500,000USD
    Capital Expenditures-81,100,000USD-47,107,000USD-34,981,000USD-26,500,000USD-25,478,000USD-35,000,000USD-24,691,000USD-38,000,000USD
    Free Cash Flow173,200,000USD135,931,000USD39,933,000USD43,400,000USD77,066,000USD-114,400,000USD-115,833,000USD82,500,000USD
    Investments857,000USD-48,160,000USD-39,146,000USD-38,414,000USD19,400,000USD-5,875,000USD-41,290,000USD-3,770,000USD
    Total Cashflows From Investing Activities-72,900,000USD-48,160,000USD-40,331,000USD-38,400,000USD36,904,000USD-41,800,000USD-41,290,000USD-120,600,000USD
    Net Borrowings-280,927,000USD87,967,000USD28,376,000USD284,006,000USD-487,900,000USD339,345,000USD171,762,000USD59,743,000USD
    Total Cash From Financing Activities-285,700,000USD18,551,000USD21,484,000USD280,100,000USD-181,483,000USD310,800,000USD146,581,000USD-42,300,000USD
    Sale Purchase Of Stock-4,430,000USD-8,439,000USD-7,503,000USD-8,700,000USD-12,942,000USD-5,601,000USD-7,064,000USD-61,611,000USD
    Change In Cash-88,000,000USD145,684,000USD62,254,000USD307,600,000USD-44,840,000USD191,700,000USD13,933,000USD-46,400,000USD
    Begin Period Cash Flow723,600,000USD577,872,000USD515,618,000USD208,000,000USD252,832,000USD61,100,000USD47,204,000USD93,600,000USD
    End Period Cash Flow635,600,000USD723,556,000USD577,872,000USD515,600,000USD207,992,000USD252,800,000USD61,137,000USD47,200,000USD
    Other Cashflows From Investing Activities7,400,000USD89,000USD1,154,000USD-88,000USD1,727,000USD-1,900,000USD-3,349,000USD14,200,000USD
    Other Cashflows From Financing Activities-378,000USD-60,977,000USD2,585,000USD4,795,000USD9,694,000USD-90,692,000USD-19,305,000USD-9,735,000USD
    Unclassified Operating Cash Flow—6,795,000USD-114,428,000USD1,391,000USD2,852,000USD37,311,000USD-26,498,000USD-95,100,000USD
    Unclassified Investing Cash Flow—47,018,000USD32,642,000USD26,602,000USD41,255,000USD—28,040,000USD-93,030,000USD
    Issuance Of Capital Stock——0USD-1,623,000USD322,557,000USD0USD——
    Unclassified Financing Cash Flow——-1,974,000USD—309,665,000USD67,748,000USD6,028,000USD-30,697,000USD
    Change To Liabilities———-3,510,000USD13,000,000USD2,673,000USD-38,577,000USD13,681,000USD
    Cash And Cash Equivalents Changes————-42,035,000USD189,490,000USD—-46,411,000USD
    Dividends Paid——————-4,840,000USD—
    Exchange Rate Changes———————-3,996,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyEurope81,817,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyLocations Excluding The United States And Europe109,420,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States199,350,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentCardiopulmonary221,576,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentNeuromodulation166,945,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentOther2,066,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyEurope75,652,000USD0001639691-26-000035
    Q1 2026Quarterly · 2026-03-31GeographyLocations Excluding The United States And Europe101,928,000USD0001639691-26-000035
    Q1 2026Quarterly · 2026-03-31GeographyUnited States184,678,000USD0001639691-26-000035
    Q1 2026Quarterly · 2026-03-31SegmentCardiopulmonary208,655,000USD0001639691-26-000035
    Q1 2026Quarterly · 2026-03-31SegmentNeuromodulation151,788,000USD0001639691-26-000035
    Q1 2026Quarterly · 2026-03-31SegmentOther1,815,000USD0001639691-26-000035
    Q4 2025Quarterly · 2025-12-31SegmentCardiopulmonary206,575,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentNeuromodulation152,724,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentOther1,622,000USDLegacy provider
    FY 2025Yearly · 2025-12-31SegmentCardiopulmonary785,385,000USD0001639691-26-000010
    FY 2025Yearly · 2025-12-31SegmentNeuromodulation592,812,000USD0001639691-26-000010
    FY 2025Yearly · 2025-12-31SegmentOther9,856,000USD0001639691-26-000010
    Q3 2025Quarterly · 2025-09-30GeographyEurope67,683,000USD0001639691-25-000150
    Q3 2025Quarterly · 2025-09-30GeographyLocations Excluding The United States And Europe99,623,000USD0001639691-25-000150
    Q3 2025Quarterly · 2025-09-30GeographyUnited States190,447,000USD0001639691-25-000150
    Q3 2025Quarterly · 2025-09-30SegmentCardiopulmonary203,218,000USD0001639691-25-000150
    Q3 2025Quarterly · 2025-09-30SegmentNeuromodulation149,525,000USD0001639691-25-000150
    Q3 2025Quarterly · 2025-09-30SegmentOther5,010,000USD0001639691-25-000150
    Q2 2025Quarterly · 2025-06-30GeographyEurope66,776,000USD0001639691-25-000102
    Q2 2025Quarterly · 2025-06-30GeographyLocations Excluding The United States And Europe97,274,000USD0001639691-25-000102
    Q2 2025Quarterly · 2025-06-30GeographyUnited States188,474,000USD0001639691-25-000102
    Q2 2025Quarterly · 2025-06-30SegmentCardiopulmonary199,272,000USD0001639691-25-000102
    Q2 2025Quarterly · 2025-06-30SegmentNeuromodulation151,670,000USD0001639691-25-000102
    Q2 2025Quarterly · 2025-06-30SegmentOther1,582,000USD0001639691-25-000102
    Q1 2025Quarterly · 2025-03-31GeographyEurope59,701,000USD0001639691-26-000035
    Q1 2025Quarterly · 2025-03-31GeographyLocations Excluding The United States And Europe87,990,000USD0001639691-26-000035
    Q1 2025Quarterly · 2025-03-31GeographyUnited States169,164,000USD0001639691-26-000035
    Q1 2025Quarterly · 2025-03-31SegmentCardiopulmonary176,320,000USD0001639691-26-000035
    Q1 2025Quarterly · 2025-03-31SegmentNeuromodulation138,893,000USD0001639691-26-000035
    Q1 2025Quarterly · 2025-03-31SegmentOther1,642,000USD0001639691-26-000035
    Q4 2024Quarterly · 2024-12-31SegmentCardiopulmonary181,668,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentNeuromodulation137,614,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentOther2,548,000USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentCardiopulmonary683,512,000USD0001639691-26-000010
    FY 2024Yearly · 2024-12-31SegmentNeuromodulation554,223,000USD0001639691-26-000010
    FY 2024Yearly · 2024-12-31SegmentOther15,702,000USD0001639691-26-000010
    Q3 2024Quarterly · 2024-09-30GeographyEurope52,815,000USD0001639691-25-000150
    Q3 2024Quarterly · 2024-09-30GeographyLocations Excluding The United States And Europe85,477,000USD0001639691-25-000150
    Q3 2024Quarterly · 2024-09-30GeographyUnited States179,828,000USD0001639691-25-000150
    Q3 2024Quarterly · 2024-09-30SegmentCardiopulmonary172,239,000USD0001639691-25-000150
    Q3 2024Quarterly · 2024-09-30SegmentNeuromodulation139,861,000USD0001639691-25-000150
    Q3 2024Quarterly · 2024-09-30SegmentOther6,020,000USD0001639691-25-000150
    Q2 2024Quarterly · 2024-06-30GeographyEurope51,258,000USD0001639691-25-000102
    Q2 2024Quarterly · 2024-06-30GeographyLocations Excluding The United States And Europe87,780,000USD0001639691-25-000102
    Q2 2024Quarterly · 2024-06-30GeographyUnited States179,537,000USD0001639691-25-000102
    Q1 2024Quarterly · 2024-03-31GeographyEurope54,341,000USD0001639691-25-000042
    Q1 2024Quarterly · 2024-03-31GeographyLocations Excluding The United States And Europe79,951,000USD0001639691-25-000042
    Q1 2024Quarterly · 2024-03-31GeographyUnited States160,620,000USD0001639691-25-000042
    FY 2023Yearly · 2023-12-31SegmentAdvanced Circulatory Support40,322,000USD0001639691-24-000021
    FY 2023Yearly · 2023-12-31SegmentCardiopulmonary588,977,000USD0001639691-24-000021
    FY 2023Yearly · 2023-12-31SegmentNeuromodulation519,710,000USD0001639691-24-000021
    FY 2023Yearly · 2023-12-31SegmentOther4,536,000USD0001639691-24-000021
    FY 2022Yearly · 2022-12-31SegmentAdvanced Circulatory Support39,301,000USD0001639691-24-000021
    FY 2022Yearly · 2022-12-31SegmentCardiopulmonary500,314,000USD0001639691-24-000021
    FY 2022Yearly · 2022-12-31SegmentNeuromodulation476,993,000USD0001639691-24-000021
    FY 2022Yearly · 2022-12-31SegmentOther5,197,000USD0001639691-24-000021
    FY 2021Yearly · 2021-12-31SegmentAdvanced Circulatory Support55,459,000USD0001639691-24-000021
    FY 2021Yearly · 2021-12-31SegmentCardiopulmonary482,979,000USD0001639691-24-000021
    FY 2021Yearly · 2021-12-31SegmentNeuromodulation456,172,000USD0001639691-24-000021
    FY 2021Yearly · 2021-12-31SegmentOther40,755,000USD0001639691-24-000021
    FY 2020Yearly · 2020-12-31SegmentAdvanced Circulatory Support42,321,000USD0001639691-23-000015
    FY 2020Yearly · 2020-12-31SegmentCardiopulmonary446,732,000USD0001639691-23-000015
    FY 2020Yearly · 2020-12-31SegmentNeuromodulation354,444,000USD0001639691-23-000015
    FY 2020Yearly · 2020-12-31SegmentOther90,744,000USD0001639691-23-000015
    FY 2019Yearly · 2019-12-31SegmentAdvanced Circulatory Support31,923,000USD0001639691-22-000013
    FY 2019Yearly · 2019-12-31SegmentCardiopulmonary504,716,000USD0001639691-22-000013
    FY 2019Yearly · 2019-12-31SegmentNeuromodulation424,547,000USD0001639691-22-000013
    FY 2019Yearly · 2019-12-31SegmentOther122,984,000USD0001639691-22-000013
    FY 2018Yearly · 2018-12-31SegmentCardiovascular681,825,000USD0001639691-21-000016
    FY 2018Yearly · 2018-12-31SegmentNeuromodulation422,990,000USD0001639691-21-000016
    FY 2018Yearly · 2018-12-31SegmentOther2,146,000USD0001639691-21-000016
    FY 2015Yearly · 2015-04-24GeographyEurope41,484,000USD0001639691-18-000016
    FY 2015Yearly · 2015-04-24GeographyNon U.S.and Europe14,362,000USD0001639691-18-000016
    FY 2015Yearly · 2015-04-24GeographyUnited States235,712,000USD0001639691-18-000016
    FY 2014Yearly · 2014-04-25GeographyEurope38,293,000USD0001639691-17-000011
    FY 2014Yearly · 2014-04-25GeographyNon U.S.and Europe16,798,000USD0001639691-17-000011
    FY 2014Yearly · 2014-04-25GeographyUnited States226,923,000USD0001639691-17-000011

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.